Article
Genetic alteration of heparan sulfate in CD11c + immune cells inhibits inflammation and facilitates pathogen clearance during influenza A virus infection.
Scientific reports - 30 Mar 2022
Kim So Young, Gupta Purva, Johns Scott C, Zuniga Elina I, Teijaro John R, Fuster Mark M
Abstract excerpt
Survival from influenza A virus (IAV) infection largely depends on an intricate balance between pathogen clearance and immunomodulation in the lung. We demonstrate that genetic alteration of the glycan heparan sulfate (HS) in CD11c + cells via Ndst1f/f CD11cCre + mutation, which inhibits HS sulfation in a major antigen presenting cell population, reduces lung inflammation by A/Puerto Rico/8/1934(H1N1) influenza...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
